Read more about Oval's approach to autoinjector development:

• Diversity is a key component of success for the medical device industry
• Sustainability Considerations for End-to-End Drug Device Solutions
• ONdrugDelivery - Computational Modelling of Injection Related Tissue Responses in Drug Delivery
• ONdrugDelivery - A New Mindset for Combination Product Development
• Informa Roundtable - Can Parenteral Drug Delivery Devices Improve Patient Outcomes When Therapies Are Administered at Home?
• OndrugDelivery - Patient Centricity - The Importance of Human Factors in the Pandemic Era
• DDF Summit Presentation - Enabling a flexible autoinjector platform for the delivery of high viscosity or large volume parenteral formulations
• Characterisation & Delivery of Ultra-viscous & non-Newtonian Formulations
• Health Europa - Meeting the challenge of delivering high volume biologic therapies
• ONdrugDelivery - Combining Human Needs with High Viscosity Formulations
• ONdrugDelivery - Function-Based Primary Packaging Design for Injecting Viscous Non-Newtonian Formulations
• ONdrugDelivery - Integrating Design and Industrialisation to Optimise Cost Quality and Time
• ONdrugDelivery - Using Polymeric PDC Technology to Improve Auto-Injector Design
• Developing a Primary Drug Container for highly viscous formulations
• Drug Characterisation - A key factor in autoinjector design for more challenging formulations
• High Viscosity Formulations - Developing a Human Solution to Autoinjector Design
• 'Smart Devices' vs 'Smart Design' - Demonstrating the value of polymeric PDC technology upon user-centric autoinjector design